Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Trevi Therapeutics, Inc. - Common Stock (NQ:TRVI)

11.71 +0.73 (+6.65%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,457,128
Open	11.02
Bid (Size)	11.70 (400)
Ask (Size)	11.71 (2,200)
Prev. Close	10.98
Today's Range	10.94 - 11.75
52wk Range	3.471 - 14.39
Shares Outstanding	60,069,512
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

December 03, 2025

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term investors should take from that divergence.

Via The Motley Fool

Performance

YTD	-1.5%	-1.5%
1 Month	-9.8%	-9.8%
3 Month	+22.6%	+22.6%
6 Month	+100.0%	+100.0%
1 Year	+171.1%	+171.1%

More News

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 28, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 27, 2025

Via The Motley Fool

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

November 27, 2025

Via The Motley Fool

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗

November 27, 2025

Via The Motley Fool

Trevi Therapeutics Inc (NASDAQ:TRVI) Reports Q3 2025 Results, Narrows Loss and Outlines Phase 3 Plans ↗

November 13, 2025

Via Chartmill

Earnings Preview For Trevi Therapeutics ↗

May 07, 2025

Via Benzinga

A Peek at Trevi Therapeutics's Future Earnings ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 03, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 09, 2025

Via Benzinga

This Adient Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 21, 2025

Via Benzinga

Dow Gains Over 100 Points; US Job Openings Increase In April ↗

June 03, 2025

Via Benzinga

Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients ↗

June 02, 2025

Via Benzinga

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

March 26, 2025

From Avalo Therapeutics

Via GlobeNewswire

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

Unusual volume stocks are being observed in Tuesday's session. ↗

March 11, 2025

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 10, 2025

Via Chartmill

Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday ↗

March 10, 2025

Via Benzinga

Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps ↗

March 10, 2025

Via Benzinga

Top movers in Monday's pre-market session ↗

March 10, 2025

Via Chartmill

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket ↗

March 10, 2025

Via Benzinga

Frequently Asked Questions

Is Trevi Therapeutics, Inc. - Common Stock publicly traded?

Yes, Trevi Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Trevi Therapeutics, Inc. - Common Stock trade on?

Trevi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Trevi Therapeutics, Inc. - Common Stock?

The ticker symbol for Trevi Therapeutics, Inc. - Common Stock is TRVI on the Nasdaq Stock Market

What is the current price of Trevi Therapeutics, Inc. - Common Stock?

The current price of Trevi Therapeutics, Inc. - Common Stock is 11.71

When was Trevi Therapeutics, Inc. - Common Stock last traded?

The last trade of Trevi Therapeutics, Inc. - Common Stock was at 01/07/26 04:00 PM ET

What is the market capitalization of Trevi Therapeutics, Inc. - Common Stock?

The market capitalization of Trevi Therapeutics, Inc. - Common Stock is 703.41M

How many shares of Trevi Therapeutics, Inc. - Common Stock are outstanding?

Trevi Therapeutics, Inc. - Common Stock has 703M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.